Helping Iraq’s Ministry of Health battle antimicrobial resistance

  21 April 2021

ANTIMICROBIAL resistance (AMR) is a growing and silent pandemic that according to the World Health Organisation (WHO) can successfully be addressed through collaborative efforts and multifaceted approaches and so have developed the ‘Antimicrobial Resistance Global Action Plan’ (AMR GAP) to contribute to a worldwide determination in discovering a solution.

Now, an expert in clinical pharmacy from the University of Huddersfield has been supporting the WHO with the global delivery of their Action Plan by hosting virtual workshops for hospital pharmacists and key focal representatives involved in antimicrobial surveillance and stewardship in Iraq.

Dr Mamoom Al Deyab is a Senior Lecturer in Clinical Pharmacy within the University’s School of Applied Sciences. Through the delivery of the workshops, he was able to distribute and explain the essential and technical expert advice issued by the WHO to Iraq’s Ministry of Health and the benefits of documenting antimicrobial usage and consumption at the hospital level, particularly for the highest priority and critically important antimicrobials, as classified by the WHO.

Further reading: Mirage News
Author(s): Mirage News
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified





Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!